NCT02502552View on ClinicalTrials.gov

Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Interventions
OTHER

blood specimen

blood specimen

Trial Locations (1)

42055

CHU Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02502552 - Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort | Biotech Hunter | Biotech Hunter